Home » ICH Advises Drugmakers to Include Geriatric Patients in Clinical Trials
ICH Advises Drugmakers to Include Geriatric Patients in Clinical Trials
November 16, 2009
Sponsors should include at least 100 geriatric patients in clinical trials of new drugs to detect clinically important differences between patient populations,
according to an International Conference on Harmonisation (ICH) question-and-answer (Q&A) document.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor